Does intensity of surveillance affect survival after surgery for sarcomas? Results of a randomized noninferiority trial

Clinical Orthopaedics and Related Research

Volumn 472, Issue 5, 2014, Pages 1568-1575

  Puri, Ajay ^a   Gulia, Ashish ^a   Hawaldar, Rohini ^a   Ranganathan, Priya ^a   Badwe, Rajendra A ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FACTORIAL DESIGN; FEMALE; FOLLOW UP; HUMAN; LIMB TUMOR; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; THORAX RADIOGRAPHY; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EXTREMITIES; FEMALE; HUMANS; INDIA; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOGRAPHY, THORACIC; SARCOMA; SOFT TISSUE NEOPLASMS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899551088     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-013-3385-9     Document Type: Article

References (22)

1. Beitler AL, Virgo KS, Johnson FE, Gibbs JF, Kraybill WG. Current follow-up strategies after potentially curative resection of extremity sarcomas: results of a survey of the members of the society of surgical oncology. Cancer. 2000;88:777-785. (Pubitemid 30091096)
2. Berrington de González A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009;169:2071-2077.
3. Cho HS, Park IH, Jeong WJ, Han I, Kim HS. Prognostic value of computed tomography for monitoring pulmonary metastases in soft tissue sarcoma patients after surgical management: a retrospective cohort study. Ann Surg Oncol. 2011;18:3392-3398.
4. Chou YS, Liu CY, Chen WM, Chen TH, Chen PC, Wu HT, Chiou HJ, Shiau CY, Wu YC, Liu CL, Chao TC, Tzeng CH, Yen CC. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease- specific survival. J Surg Oncol. 2012;106:155-161.
5. Cool P, Grimer R, Rees R. Surveillance in patients with sarcoma of the extremities. Eur J Surg Oncol. 2005;31:1020-1024. (Pubitemid 41671117)
6. Emens LA, Davidson NE. The follow-up of breast cancer. Semin Oncol. 2003;30:338-348. (Pubitemid 36706558)
7. Fung-Kee-Fung M, Dodge J, Elit L, Lukka H, Chambers A, Oliver T. Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol. 2006;101:520-529. (Pubitemid 43729963)
8. Gerrand CH, Billingham LJ, Woll PJ, Grimer RJ. Follow up after primary treatment of soft tissue sarcoma: a survey of current practice in the United Kingdom. Sarcoma. 2007;2007:34128.
9. Goel A, Christy ME, Virgo KS, Kraybill WG, Johnson FE. Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma. Int J Oncol. 2004;25:429-435.
10. Johnson FE, Sakata K, Sarkar S, Audisio RA, Kraybill WG, Gibbs JF, Beitler AL, Virgo KS. Patient surveillance after treatment for soft-tissue sarcoma. Int J Oncol. 2011;38:233-239.
11. Kane JM 3rd. Surveillance strategies for patients following surgical resection of soft tissue sarcomas. Curr Opin Oncol. 2004;16:328-332.
12. Korholz D, Verheyen J, Kemperdick HF, Gobel U. Evaluation of follow-up investigations in osteosarcoma patients: suggestions for an effective follow-up program. Med Pediatr Oncol. 1998;30:52-58. (Pubitemid 128765913)
13. Lack EE, Steinberg SM, White DE, Kinsella T, Glatstein E, Chang AE, Rosenberg SA. Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas. J Surg Oncol. 1989;41:263-273. (Pubitemid 19200461)
14. Meyerhardt JA, Mayer RJ. Follow-up strategies after curative resection of colorectal cancer. Semin Oncol. 2003;30:349-360. (Pubitemid 36706559)
15. Meyers MO, Yeh JJ, Frank J, Long P, Deal AM, Amos KD, Ollila DW. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging. Ann Surg Oncol. 2009;16:941-947.
16. Pocock SJ. The pros and cons of noninferiority trials. Fundam Clin Pharmacol. 2003;17:483-490. (Pubitemid 36920651)
17. Postovsky S, Barzilai M, Meller I, Kollander Y, Futerman B, Ben Arush MW. Does regular follow-up influence the survival of patients with sarcoma after recurrence? The Miri Shitrit pediatric oncology department experience. J Pediatr Hematol Oncol. 2008;30:189-195. (Pubitemid 351496731)
18. Sawamura C, Matsumoto S, Shimoji T, Okawa A, Ae K. How long should we follow patients with soft tissue sarcomas? Clin Orthop Relat Res. 2013 May 29 [Epub ahead of print].
19. Smith TJ, Hillner BE. Bending the cost curve in cancer care. N Engl J Med. 2011;364:2060-2065.
20. The ESMO/European Sarcoma Network Working Group. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii100-109.
21. Whooley BP, Gibbs JF, Mooney MM, McGrath BE, Kraybill WG. Primary extremity sarcoma: what is the appropriate follow-up? Ann Surg Oncol. 2000;7:9-14. (Pubitemid 30078487)
22. Whooley BP, Mooney MM, Gibbs JF, Kraybill WG. Effective follow-up strategies in soft tissue sarcoma. Semin Surg Oncol. 1999;17:83-87. (Pubitemid 29305120)